ArticleInflammatory bowel diseases2025

Prevalence of Irritable Bowel Syndrome Based on Rome IV Criteria in Patients in Biochemical and Endoscopic Remission From Newly Diagnosed Inflammatory Bowel Disease: One- and Three-Year Results (the IBSEN III Cohort).

Bjorn Christian Olsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.